Recombinant derivatives of botulinum neurotoxin A engineered for trafficking studies and neuronal delivery.
about
Current status and future directions of botulinum neurotoxins for targeting pain processingAtoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasmWhat next for botulism vaccine development?Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A.Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivativeTowards new uses of botulinum toxin as a novel therapeutic toolPhage selection assisted by Sfp phosphopantetheinyl transferase-catalyzed site-specific protein labeling.Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle RecyclingPre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety.Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery.Current strategies for designing antidotes against botulinum neurotoxins.Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting.Botulinum Neurotoxin Subtype A4 Originating from Nontoxigenic Clostridium botulinum.Engineering of Botulinum Neurotoxins for Biomedical Applications.
P2860
Q26778129-19ABB265-5725-4346-8E65-D8E300FE48CFQ28660367-B2719BA7-CD43-44A2-ACAD-A635F57B27BEQ34343808-C08D9EFE-870B-4865-97F7-32A2AF70BA9BQ34595178-72563F5A-1E91-4790-AB13-83C4938F184CQ34612698-8158D6EB-9FF5-43C2-BB66-08AD7216FC47Q35357741-2DFA6366-BE03-4F6B-AFF4-53026D867BBEQ35534477-346D6DA5-58E7-4516-97F1-EFC621A028E8Q35538302-1D6BEA73-2983-49E1-A2E7-BA6C3FE61352Q35542237-4CFD4648-D656-4A83-A3A6-715494A2F0A6Q35710270-8341F0D6-B19A-417C-B702-0F9D2F0559E2Q37147931-0E77475F-8CD3-491C-ABF8-19164C678B92Q37654972-0088F2C6-2309-45AD-AC56-D93EE5D589CFQ38187441-F02F086E-5E5C-4E34-8153-CD32F80624B6Q39207459-51259CC0-CF01-4976-9580-FB77851DA7C8Q40068037-26DAF6E9-69F7-480F-A55A-6AA99812D93AQ42600051-F8D86416-1687-4930-97BA-7BC74905F826Q43045483-A764F9E1-E8B9-4990-BB75-5034796F8EE4Q55460011-B99C5997-6B86-4CF9-8016-9AAE6509BC63
P2860
Recombinant derivatives of botulinum neurotoxin A engineered for trafficking studies and neuronal delivery.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Recombinant derivatives of bot ...... studies and neuronal delivery.
@en
Recombinant derivatives of bot ...... studies and neuronal delivery.
@nl
type
label
Recombinant derivatives of bot ...... studies and neuronal delivery.
@en
Recombinant derivatives of bot ...... studies and neuronal delivery.
@nl
prefLabel
Recombinant derivatives of bot ...... studies and neuronal delivery.
@en
Recombinant derivatives of bot ...... studies and neuronal delivery.
@nl
P2093
P2860
P1476
Recombinant derivatives of bot ...... studies and neuronal delivery.
@en
P2093
Philip A Band
Steven Blais
Thomas A Neubert
Timothy J Cardozo
P2860
P356
10.1016/J.PEP.2009.12.013
P577
2010-01-04T00:00:00Z